首页> 美国卫生研究院文献>BMC Research Notes >Modulation of endoglin expression in islets of langerhans by VEGF reveals a novel regulator of islet endothelial cell function
【2h】

Modulation of endoglin expression in islets of langerhans by VEGF reveals a novel regulator of islet endothelial cell function

机译:血管内皮生长因子对蓝瑟汉斯胰岛内皮糖蛋白表达的调节揭示了胰岛内皮细胞功能的新型调节剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEndoglin/CD105 is an auxiliary receptor for transforming growth factor-β with established roles in vascular remodelling. It has recently been shown that heterozygous endoglin deficiency in mice decreases insulin secretion in an animal model of obesity, highlighting a potential role for endoglin in the regulation of islet function. We have previously identified two different populations of endoglin expressing cells in human and mouse islets which are: (i) endothelial cells (ECs) and (ii) islet mesenchymal stromal cells. The contribution of islet EC endoglin expression to islet development and sensitivity to VEGF is unknown and is the focus of this study.
机译:背景Endoglin / CD105是用于转化生长因子-β的辅助受体,在血管重塑中具有确定的作用。最近显示,在肥胖动物模型中,小鼠杂合内皮糖蛋白缺乏会降低胰岛素分泌,这突显了内皮糖蛋白在胰岛功能调节中的潜在作用。我们先前已经确定了人类和小鼠胰岛中内皮糖蛋白表达细胞的两个不同种群,它们是:(i)内皮细胞(EC)和(ii)胰岛间充质基质细胞。胰岛EC内皮糖蛋白表达对胰岛发育和对VEGF的敏感性的贡献尚不清楚,这是本研究的重点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号